Processing 00000000.tx.1: The law of mass action applied to neurodegenerative disease: a hypothesis concerning the etiology and pathogenesis of complex diseases Andrew Singleton, Amanda Myers and John Hardy* Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Building 10, Room 6C103, MSC1589, Bethesda, MD 20892, USA Received January 2, 2004; 

Phrase: "The law of mass action"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0023150:Law [Regulation or Law]
   760   C0220866:Law [Regulation or Law]
   760   C0728724:law [Regulation or Law]
   760   C1947938:Law [Intellectual Product]
   760   C1947939:Law [Occupation or Discipline]

Phrase: "applied to neurodegenerative disease"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   833   C0524851:Neurodegenerative Disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0185125:Applied [Health Care Activity]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "a hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "concerning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2699424:Concern [Idea or Concept]

Phrase: "the etiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:aetiology [Functional Concept]
  1000   C1314792:Aetiology [Functional Concept]
  1000   C1524003:Etiology [Conceptual Entity]

Phrase: "and"

Phrase: "pathogenesis of complex diseases Andrew Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0543483:pathogenesis [Functional Concept]
   753   C0699748:Pathogenesis [Pathologic Function]

Phrase: "Amanda Myers"

Phrase: "and"

Phrase: "John Hardy"

Phrase: "* Laboratory of Neurogenetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0022877:Laboratory [Manufactured Object,Organization]
   790   C3244292:laboratory [Functional Concept]

Phrase: "National Institute on Aging,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1955974:National Institute on Aging [Health Care Related Organization]
   812   C0001811:Ageing [Organism Function]
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]
   812   C3245503:national [Intellectual Product]
   779 E C0001779:Age [Organism Attribute]

Phrase: "National Institutes of Health,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "Building"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1547706:Building [Functional Concept]
  1000   C1999269:Building [Manufactured Object]
   966 E C1707059:Build [Conceptual Entity]

Phrase: "10,"

Phrase: "Room 6C103,"

Phrase: "MSC1589,"

Phrase: "Bethesda,"

Phrase: "MD 20892,"

Phrase: "USA Received January 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0041703:USA [Geographic Area]
   812   C1514756:Received [Qualitative Concept]

Phrase: "2004"

Phrase: ";"
Processing 00000000.tx.2: Revised February 3, 2004; 

Phrase: "Revised February 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "2004"

Phrase: ";"
Processing 00000000.tx.3: Accepted February 9, 2004  ABSTRACT TOP ABSTRACT INTRODUCTION THE DISEASES METHODOLOGICAL CONSIDERATIONS CONCLUSIONS AND PREDICTIONS REFERENCES  Loci underlying autosomal dominant forms of most neurodegenerative disease have been identified: prion mutations cause Gerstmann Straussler syndrome and hereditary CreuzfeldtJakob disease, tau mutations cause autosomal dominant frontal temporal dementia, and -synuclein mutations cause autosomal dominant Parkinson's disease. 

Phrase: "Accepted February 9,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2004  ABSTRACT TOP ABSTRACT INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1293116:Introduction [Health Care Activity]
   804   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "THE DISEASES METHODOLOGICAL CONSIDERATIONS CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1707478:Conclusions [Idea or Concept]

Phrase: "AND"

Phrase: "PREDICTIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681842:predictions [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]

Phrase: "underlying"

Phrase: "autosomal dominant forms of most neurodegenerative disease"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ":"

Phrase: "prion mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Gerstmann Straussler syndrome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017495:Gerstmann-Straussler Syndrome [Disease or Syndrome]
   913   C0017494:Gerstmann Syndrome [Mental or Behavioral Dysfunction]
   827   C0039082:Syndrome [Disease or Syndrome]

Phrase: "and"

Phrase: "hereditary CreuzfeldtJakob disease,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   913   C0019247:Hereditary Disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "tau mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "autosomal dominant frontal temporal dementia,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   853   C1260405:Frontal dementia [Disease or Syndrome]
   804   C0011265:dementia [Mental or Behavioral Dysfunction]
   804   C0497327:Dementia [Mental or Behavioral Dysfunction]
   704 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and -"

Phrase: "synuclein mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "autosomal dominant Parkinson's disease."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C3489791:Parkinson Disease, Autosomal Dominant [Disease or Syndrome]
   861   C0030567:Parkinson Disease [Disease or Syndrome]
   861   C1521736:Parkinson's Disease [Functional Concept]
   861   C2681933:PARKINSON DISEASE [Gene or Genome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
   712   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.4: In all these cases, the pathogenic mutation is in the protein that is deposited in the diseased tissue and in these cases the whole protein is deposited. 

Phrase: "In all"

Phrase: "these cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "the pathogenic mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is in the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "is"

Phrase: "deposited in the diseased tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0040300:Tissue [Tissue]
   760   C0333562:deposited [Functional Concept]
   760   C1547928:Tissue [Intellectual Product]

Phrase: "and in these cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0868928:Cases [Functional Concept]
   770   C1515981:And [Idea or Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "the whole protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0444667:Whole [Quantitative Concept]

Phrase: "is"

Phrase: "deposited."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:deposited [Functional Concept]
Processing 00000000.tx.5: In Alzheimer's disease, mutations in APP or presenilin 1 or 2 cause autosomal dominant disease and these are the substrate and proteases, respectively, which are responsible for the production of the deposited peptide, A. 

Phrase: "In Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "mutations in APP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "or"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "autosomal dominant disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   734   C0443147:Autosomal dominant [Intellectual Product]

Phrase: "and"

Phrase: "these"

Phrase: "are"

Phrase: "the substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "proteases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Proteases [Enzyme]

Phrase: "respectively,"

Phrase: "which"

Phrase: "are"

Phrase: "responsible for the production of the deposited peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]

Phrase: "A."
Processing 00000000.tx.6: Thus, in all cases, the mutations lead to the disease by a mechanism that involves the deposition process. 

Phrase: "Thus,"

Phrase: "in all cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "the mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "lead to the disease"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0012634:Disease [Disease or Syndrome]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "by a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "involves"

Phrase: "the deposition process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.7: We briefly review this remarkably predictable biology, but also point out that it seems sporadic forms of all these diseases are predisposed to by genetic variability at the same loci, strongly suggesting that the quantity of the normal protein produced influences risk for the sporadic forms of the disease. 

Phrase: "We briefly"

Phrase: "review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "this remarkably predictable biology,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0005532:Biology [Biomedical Occupation or Discipline]
   755 E C0205460:Biologic [Qualitative Concept]
   755 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "but"

Phrase: "also"

Phrase: "point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "that"

Phrase: "it"

Phrase: "seems"

Phrase: "sporadic forms of all"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "these diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "are"

Phrase: "predisposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231203:Predisposed [Functional Concept]

Phrase: "to by genetic variability"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0314603:Genetic [Functional Concept]
   770   C1883351:To [Qualitative Concept]
   770   C2827666:Variability [Conceptual Entity]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "at the same loci,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "strongly"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the quantity of the normal protein produced influences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0332587:Normal quantity [Qualitative Concept]
   744   C1265611:Quantity [Quantitative Concept]
   744   C1554108:Quantity [Intellectual Product]
   744   C1561573:Quantity [Intellectual Product]

Phrase: "risk for the sporadic forms of the disease."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   767   C1281905:disease risk [Finding]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0035647:Risk [Qualitative Concept]
   744   C0205422:Sporadic [Temporal Concept]
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   711 E C1522492:Form [Functional Concept]
Processing 00000000.tx.8: The evidence for this assertion is strongest in Parkinson's disease (PD), where genetic variability in -synuclein expression affects risk of developing disease, although the oldest evidence for the notion that increased expression of normal sequence protein can lead to disease comes from the observation of Alzheimer's disease in trisomy 21 cases. 

Phrase: "The evidence for this assertion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "is"

Phrase: "strongest in Parkinson's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0442821:Strong [Qualitative Concept]

Phrase: "(PD"

Phrase: ")"

Phrase: ","

Phrase: "where genetic variability in -synuclein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   822   C1868500:Variable expression [Finding]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "risk of developing disease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1281905:disease risk [Finding]
   770   C0035647:Risk [Qualitative Concept]

Phrase: "although"

Phrase: "the oldest evidence for the notion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332120:Evidence [Functional Concept]

Phrase: "that increased expression of normal sequence protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "lead to disease"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0012634:Disease [Disease or Syndrome]
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]

Phrase: "comes from the observation of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0302523:Observation [Research Activity]
   748   C0700325:observation [Health Care Activity]
   748   C1964257:Observation [Diagnostic Procedure]

Phrase: "in trisomy 21 cases."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]
   734   C0013080:Trisomy 21 [Congenital Abnormality,Disease or Syndrome]
   734   C3537167:Trisomy 21 [Cell or Molecular Dysfunction]
Processing 00000000.tx.9: From these observations, we make predictions concerning the etiology and pathogenesis of neurodegenerative diseases in general.  

Phrase: "From these observations,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "we"

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "predictions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681842:predictions [Idea or Concept]

Phrase: "concerning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2699424:Concern [Idea or Concept]

Phrase: "the etiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:aetiology [Functional Concept]
  1000   C1314792:Aetiology [Functional Concept]
  1000   C1524003:Etiology [Conceptual Entity]

Phrase: "and"

Phrase: "pathogenesis of neurodegenerative diseases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0543483:pathogenesis [Functional Concept]
   770   C0699748:Pathogenesis [Pathologic Function]

Phrase: "in general."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]
Processing 00000000.tx.10: INTRODUCTION TOP ABSTRACT INTRODUCTION THE DISEASES METHODOLOGICAL CONSIDERATIONS CONCLUSIONS AND PREDICTIONS REFERENCES  In the last 15 years there has been remarkable progress in our understanding of the etiology of the autosomal dominant neurodegenerative diseases. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION"

Phrase: "THE DISEASES METHODOLOGICAL CONSIDERATIONS CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1707478:Conclusions [Idea or Concept]

Phrase: "AND"

Phrase: "PREDICTIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681842:predictions [Idea or Concept]

Phrase: "REFERENCES  In the last 15 years there"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0439234:years [Temporal Concept]
   748   C1514811:Reference [Idea or Concept]
   748   C1706462:Reference [Conceptual Entity]
   714 E C0439508:/year [Temporal Concept]

Phrase: "has"

Phrase: "been"

Phrase: "remarkable progress in our understanding of the etiology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1272688:progress [Functional Concept]
   744   C1280477:Progress [Functional Concept]

Phrase: "of the autosomal dominant neurodegenerative diseases."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   812   C0012634:Diseases [Disease or Syndrome]
   741 E C1836721:MALS [Finding]
   741 E C3538764:MALS [Gene or Genome]
   741 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.11: The loci underlying the autosomal dominant forms of CreuzfeldtJakob disease (1), frontal temporal dementia (2) and Parkinson's disease have been identified (3). 

Phrase: "The loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]

Phrase: "underlying"

Phrase: "the autosomal dominant forms of CreuzfeldtJakob disease"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "frontal temporal dementia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C1260405:Frontal dementia [Disease or Syndrome]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.12: In each case, the underlying locus has encoded the protein that is often deposited in the disease. 

Phrase: "In each case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "the underlying locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "has"

Phrase: "encoded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679058:encoded [Mental Process]
  1000   C2700640:Encoded [Activity]

Phrase: "the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "is"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "deposited in the disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0012634:Disease [Disease or Syndrome]
   770   C0333562:deposited [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.13: In CreuzfeldtJakob disease, this is the prion protein: in frontal temporal dementia, it is tau, and in Parkinson's disease it is -synuclein. 

Phrase: "In CreuzfeldtJakob disease,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "this"

Phrase: "is"

Phrase: "the prion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
  1000   C1418941:PRION PROTEIN [Gene or Genome]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "in frontal temporal dementia,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C1260405:Frontal dementia [Disease or Syndrome]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "it"

Phrase: "is"

Phrase: "tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "and in Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1515981:And [Idea or Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "it is -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.14: In Alzheimer's disease, the situation is a little more complex in that the deposited peptide, A, is derived from a fragment of the APP protein when metabolized by the -secretase complex: a key component of this complex are the presenilins and mutations in either APP or presenilin 1 or 2 can lead to disease (46). 

Phrase: "In Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "the situation"

Phrase: "is"

Phrase: "a little more complex in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "the deposited peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "A,"

Phrase: "is"

Phrase: "derived from a fragment of the APP protein"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   775   C0002722:Amyloid A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   775   C0002723:Amyloid A Precursor [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Amyloid A
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   757   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0332255:fragment [Functional Concept]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1441547:Derived [Qualitative Concept]
   739   C1708096:Fragment [Qualitative Concept]
   739   C1709634:Precursor [Idea or Concept]
   739   C3245521:derived [Idea or Concept]

Phrase: "when"

Phrase: "metabolized by the -secretase complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439855:Complex [Qualitative Concept]
   760   C1524026:Metabolized [Cell Function]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: ":"

Phrase: "a key component of this complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "are"

Phrase: "the presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "mutations in either APP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "or"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "can"

Phrase: "lead to disease"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0012634:Disease [Disease or Syndrome]
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.15: These findings are well established and have driven therapeutics research, especially because they have allowed the development of animal models of these diseases as well as defined therapeutic targets (7). 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "well established"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205170:Well [Qualitative Concept]
   861   C0443211:Established [Qualitative Concept]
   861   C1272684:Established [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "have"

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "therapeutics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039796:Therapeutics [Therapeutic or Preventive Procedure]
  1000   C0723712:therapeutics [Organic Chemical,Pharmacologic Substance]

Phrase: "research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: ","

Phrase: "especially"

Phrase: "because"

Phrase: "they"

Phrase: "have"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "the development of animal models of these diseases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   750   C0920595:development model [Intellectual Product]
   744   C0243107:development [Physiologic Function]
   744   C0678723:Development [Organism Function]
   744   C1527148:Development [Functional Concept]

Phrase: "as well as"

Phrase: "defined therapeutic targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521840:Target [Functional Concept]
   793   C2986546:TARGET [Diagnostic Procedure]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.16: In each of these examples, the precise pathologic species of protein is obscure, if there is one, and it is debated whether the deposits themselves, or some intermediate species such as an oligomer, are responsible. 

Phrase: "In each"

Phrase: "of these examples,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707959:Example [Conceptual Entity]

Phrase: "the precise pathologic species of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705920:Species [Conceptual Entity]

Phrase: "is"

Phrase: "obscure,"

Phrase: "if"

Phrase: "there"

Phrase: "is"

Phrase: "one,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "debated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0870392:debate [Activity]

Phrase: "whether"

Phrase: "the deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposits [Functional Concept]

Phrase: "themselves,"

Phrase: "or"

Phrase: "some intermediate species such as an oligomer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705920:Species [Conceptual Entity]

Phrase: "are"

Phrase: "responsible."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1273518:Responsible [Finding]
Processing 00000000.tx.17: This has been extensively investigated, with the balance of recent data favoring smaller intermediate species as the toxic entities (8); 

Phrase: "This"

Phrase: "has"

Phrase: "been"

Phrase: "extensively"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: ","

Phrase: "with the balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014653:Balance [Organism Function]
  1000   C0205415:Balance [Functional Concept]
  1000   C0560184:Balance [Finding]

Phrase: "of recent data favoring smaller intermediate species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1705920:Species [Conceptual Entity]

Phrase: "as the toxic entities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1551338:Entity [Entity]

Phrase: "(8"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.18: however, the generality of the fact that the mutated protein in each example can be deposited suggests that the process of pathogenicity is related to, although perhaps separable from, the process of deposition. 

Phrase: "however,"

Phrase: "the generality of the fact"

Phrase: "that"

Phrase: "the mutated protein in each example"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0298973:mutated protein [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "be"

Phrase: "deposited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:deposited [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the process of pathogenicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1184743:Process [Body Part, Organ, or Organ Component]
   770   C1522240:Process [Phenomenon or Process]

Phrase: "is"

Phrase: "related to,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0439849:Related [Qualitative Concept]
   833   C0445223:Related [Finding]
   799 E C0163712:Relate [Organic Chemical]

Phrase: "although"

Phrase: "perhaps separable from,"

Phrase: "the process of deposition."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1184743:Process [Body Part, Organ, or Organ Component]
   770   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.19: By studying the autosomal dominant forms of these and other diseases, researchers hope to gain insight into the more common, sporadic forms, and from a mechanistic perspective, this has certainly been the case. 

Phrase: "By studying"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the autosomal dominant forms of these"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "other diseases,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "researchers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035173:Researchers [Professional or Occupational Group]

Phrase: "hope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392347:Hope [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "insight into the more common, sporadic forms,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0233820:Insight [Mental Process]

Phrase: "and from a mechanistic perspective,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1515981:And [Idea or Concept]

Phrase: "this"

Phrase: "has"

Phrase: "certainly"

Phrase: "been"

Phrase: "the case."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]
Processing 00000000.tx.20: However, perhaps more surprisingly, over this last 4 years, it has become clear that, in the case of many of these diseases at least, the haplotype of the Mendelian pathogenic locus influences the disease risk for sporadic disease. 

Phrase: "However,"

Phrase: "perhaps more surprisingly,"

Phrase: "over this last 4 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: "it"

Phrase: "has"

Phrase: "become"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that,"

Phrase: "in the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of many"

Phrase: "of these diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "at least,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "the haplotype of the Mendelian pathogenic locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0018591:Haplotype [Organism Attribute]

Phrase: "influences"

Phrase: "the disease risk for sporadic disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1281905:disease risk [Finding]
   753   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.21: In this review, we briefly summarise these data, and then make predictions concerning the etiology and pathogenesis of these and other neurodegenerative diseases. 

Phrase: "In this review,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "we briefly"

Phrase: "summarise"

Phrase: "these data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "predictions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681842:predictions [Idea or Concept]

Phrase: "concerning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2699424:Concern [Idea or Concept]

Phrase: "the etiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:aetiology [Functional Concept]
  1000   C1314792:Aetiology [Functional Concept]
  1000   C1524003:Etiology [Conceptual Entity]

Phrase: "and"

Phrase: "pathogenesis of these"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0543483:pathogenesis [Functional Concept]
   790   C0699748:Pathogenesis [Pathologic Function]

Phrase: "and"

Phrase: "other neurodegenerative diseases."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.22: First, though, it is worth noting what a haplotypic association means from a mechanistic perspective: in the absence of coding changes, a haplotypic association implies there is genetic variability either in the amount of expression of the protein, or in the alternate splicing of the protein, and that this contributes to disease risk.  

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "though"

Phrase: ","

Phrase: "it"

Phrase: "is worth noting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1316572:Note [Clinical Attribute]
   756   C1317574:Note [Intellectual Product]
   756   C1369612:Note [Clinical Attribute]

Phrase: "what a haplotypic association means from a mechanistic perspective"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C1704970:Means [Conceptual Entity]
   708 E C0444504:Mean [Quantitative Concept]
   708 E C2347634:Mean [Quantitative Concept]
   708 E C2348143:Mean [Quantitative Concept]

Phrase: ":"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of coding changes,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "a haplotypic association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "implies"

Phrase: "there"

Phrase: "is"

Phrase: "genetic variability either in the amount of expression of the protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C2827666:Variability [Conceptual Entity]
   718   C1868500:Variable expression [Finding]

Phrase: "or in the alternate splicing of the protein,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0002345:Alternate Splicing [Genetic Function]
   767   C0376437:Protein Splicing [Genetic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0035687:Splicing [Genetic Function]
   744   C0332270:alternate [Functional Concept]
   744   C1523987:Alternate [Conceptual Entity]
   744   C2610186:splicing [Genetic Function]

Phrase: "and"

Phrase: "that"

Phrase: "this"

Phrase: "contributes to disease risk."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C1281905:disease risk [Finding]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0035647:Risk [Qualitative Concept]
   770   C1880177:Contribute [Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.23: THE DISEASES TOP ABSTRACT INTRODUCTION THE DISEASES METHODOLOGICAL CONSIDERATIONS CONCLUSIONS AND PREDICTIONS REFERENCES  Prion diseases The prion gene has two common coding variants in Caucasian populations: one with prion M129 the other with prion V129 (9,10). 

Phrase: "THE DISEASES TOP ABSTRACT INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1293116:Introduction [Health Care Activity]
   812   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "THE DISEASES METHODOLOGICAL CONSIDERATIONS CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1707478:Conclusions [Idea or Concept]

Phrase: "AND"

Phrase: "PREDICTIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681842:predictions [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Prion diseases"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0162534:Prion Diseases [Disease or Syndrome]
   966 E C3536911:Prion Disease [Pathologic Function]
   861   C0012634:Diseases [Disease or Syndrome]
   861   C0033164:Prion [Amino Acid, Peptide, or Protein]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "The prion gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "has"

Phrase: "two common coding variants in Caucasian populations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:variants [Qualitative Concept]

Phrase: ":"

Phrase: "one with prion M129"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "the other with prion V129"

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.24: It has long been recognized that homozygosity at codon 129 predisposes to sporadic disease, presumably because of the necessity of prionprion interactions and symmetry considerations (9,10). 

Phrase: "It"

Phrase: "has"

Phrase: "long"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205166:Long [Qualitative Concept]
  1000   C1706317:Long [Qualitative Concept]

Phrase: "been"

Phrase: "recognized"

Phrase: "that homozygosity at codon 129"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019904:Homozygosity [Organism Attribute]

Phrase: "predisposes to sporadic disease,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205422:Sporadic [Temporal Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "presumably because of the necessity of prionprion interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "symmetry considerations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0518609:considerations [Finding]

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.25: However, in addition to this well-established risk, recent genetic data have shown that the prion haplotype confers additional risk to idiopathic disease (11), clearly suggesting that genetic variability in prion expression contributes to disease risk. 

Phrase: "However,"

Phrase: "in addition to this well-established risk,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035647:Risk [Qualitative Concept]

Phrase: "recent genetic data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the prion haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]

Phrase: "confers"

Phrase: "additional risk to idiopathic disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "clearly"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that genetic variability in prion expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C2827666:Variability [Conceptual Entity]
   748   C1868500:Variable expression [Finding]

Phrase: "contributes to disease risk."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C1281905:disease risk [Finding]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0035647:Risk [Qualitative Concept]
   770   C1880177:Contribute [Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.26: While these genetic data do not establish whether high expressors or low expressors are more susceptible, and since prion knockout mice are completely resistant to disease (12), it is most parsimonious to expect that those who express high levels of prion protein, and are homozygotes at codon 129, are most susceptible to disease. 

Phrase: "While"

Phrase: "these genetic data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "whether"

Phrase: "high expressors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0491816:EXPRESSOR [Medical Device]

Phrase: "or"

Phrase: "low expressors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0491816:EXPRESSOR [Medical Device]

Phrase: "are"

Phrase: "more susceptible,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231204:Susceptible [Functional Concept]
   861   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "and"

Phrase: "since prion knockout mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0206745:Knock-out Mice [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "completely resistant to disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332325:Resistant to [Functional Concept]
           Resistant
   770   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "most parsimonious to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205393:Most [Quantitative Concept]

Phrase: "expect"

Phrase: "that"

Phrase: "those who"

Phrase: "express"

Phrase: "high levels of prion protein,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0428479:Protein level [Laboratory or Test Result]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "are"

Phrase: "homozygotes at codon 129,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019904:Homozygotes [Organism Attribute]

Phrase: "are"

Phrase: "most susceptible to disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0231204:Susceptible [Functional Concept]
   770   C2827758:SUSCEPTIBLE [Laboratory or Test Result]
Processing 00000000.tx.27: Alzheimer's disease Extensive sequencing of the APP gene in late-onset Alzheimer's disease has failed to identify mutations (13). 

Phrase: "Alzheimer's disease Extensive sequencing of the APP gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0002518:protein sequencing [Amino Acid Sequence]
   757   C0751971:Protein Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   757   C1294197:Gene Sequencing [Laboratory Procedure]
   739   C1553778:Sequencing [Intellectual Product]
   739   C1561491:Sequencing [Functional Concept]

Phrase: "in late-onset Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "has"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.28: However, analysis of data from sibpairs affected with late-onset Alzheimer's disease has consistently suggested that APP is a locus for this form of disease (14,15). 

Phrase: "However,"

Phrase: "analysis of data"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0010992:Data Analysis [Occupational Activity]
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "from sibpairs"

Phrase: "affected with late-onset Alzheimer's disease"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   901   C0494463:Alzheimer's disease with late onset [Mental or Behavioral Dysfunction]
           Alzheimer Disease, Late Onset
   814   C0814122:late disease onset [Finding]
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   783   C0277793:disease onset [Temporal Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0205087:Late [Temporal Concept]
   753   C0332162:Onset [Qualitative Concept]
   753   C0392760:Affected [Functional Concept]
   753   C1314939:Affected [Functional Concept]
   719 E C0001721:Affect [Mental Process]

Phrase: "has"

Phrase: "consistently"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "a locus for this form of disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1708726:Locus [Gene or Genome]

Phrase: "(14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.29: This suggests that genetic variability at the APP locus contributes to disease risk, although the precise variability has not been identified. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that genetic variability at the APP locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2827666:Variability [Conceptual Entity]

Phrase: "contributes to disease risk,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C1281905:disease risk [Finding]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0035647:Risk [Qualitative Concept]
   770   C1880177:Contribute [Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "although"

Phrase: "the precise variability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2827666:Variability [Conceptual Entity]
   789 E C0439828:Variable [Qualitative Concept]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.30: Such a finding is consistent with the longstanding observation that individuals with trisomy 21 inevitably develop Alzheimer pathology by their fifth decade (16); 

Phrase: "Such"

Phrase: "a finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "is"

Phrase: "consistent with the longstanding observation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that individuals with trisomy 21 inevitably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0027361:Individual [Population Group]
   719   C0237401:Individual [Human]

Phrase: "develop"

Phrase: "Alzheimer pathology by their fifth decade"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0030664:Pathology [Biomedical Occupation or Discipline]
   753   C0205469:pathology [Functional Concept]
   753   C0677042:pathology [Pathologic Function]

Phrase: "(16"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.31: however, those few cases of Down syndrome caused by triplication of chromosome 21 distal to the APP gene do not develop Alzheimer's disease (17). 

Phrase: "however,"

Phrase: "those few cases of Down syndrome"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "caused by triplication of chromosome 21"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0008664:Chromosome 21 [Cell Component]
   753   C0008633:Chromosome [Cell Component]
   748   C0041107:Chromosomal Triplication [Disease or Syndrome]
   719   C0015127:cause [Functional Concept]
   719   C1524003:Cause [Conceptual Entity]

Phrase: "distal to the APP gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205108:Distal [Spatial Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "develop"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.32: Thus, having three copies of the APP gene leads to Alzheimer pathology in the fifth decade and as yet unidentified genetic variability at the APP locus appears to contribute to disease risk. 

Phrase: "Thus,"

Phrase: "having"

Phrase: "three copies of the APP gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1948062:Copies [Manufactured Object]

Phrase: "leads to Alzheimer pathology"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0030664:Pathology [Biomedical Occupation or Discipline]
   770   C0181586:leads [Medical Device]
   770   C0205469:pathology [Functional Concept]
   770   C0677042:pathology [Pathologic Function]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the fifth decade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2981279:Decade [Quantitative Concept]

Phrase: "and as yet unidentified genetic variability"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0205427:Unidentified [Qualitative Concept]
   753   C0314603:Genetic [Functional Concept]
   753   C1515981:And [Idea or Concept]
   753   C2827666:Variability [Conceptual Entity]

Phrase: "at the APP locus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1708726:Locus [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contribute to disease risk."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C1281905:disease risk [Finding]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0035647:Risk [Qualitative Concept]
   770   C1880177:Contribute [Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.33: Frontal temporal dementia: tangle diseases Mutations in the tau gene cause many cases of autosomal dominant frontal temporal dementia in which there is tau pathology. 

Phrase: "Frontal temporal dementia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C1260405:Frontal dementia [Disease or Syndrome]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: ":"

Phrase: "tangle diseases Mutations in the tau gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "many cases of autosomal dominant frontal temporal dementia"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   744   C0868928:Cases [Functional Concept]
   744   C1533148:Cases [Quantitative Concept]
   711 E C1706255:CASE [Medical Device]
   711 E C1706256:Case [Conceptual Entity]

Phrase: "in which there"

Phrase: "is"

Phrase: "tau pathology."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]
Processing 00000000.tx.34: There are many sporadic diseases in which tau pathology occurs, usually as tangles, but also as Pick bodies or Argyrophilic grains (18). 

Phrase: "There"

Phrase: "are"

Phrase: "many sporadic diseases in which tau pathology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0012634:Diseases [Disease or Syndrome]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "usually as tangles,"

Phrase: "but"

Phrase: "also"

Phrase: "as"

Phrase: "Pick bodies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   966   C3546648:Pick body [Cell Component]
   861   C0242821:bodies [Human]
   861   C1707391:Pick [Activity]
   861   C1826583:PICK [Gene or Genome]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "or"

Phrase: "Argyrophilic grains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0007757:Grains [Food]
   861   C0086369:Grains [Plant]
   827 E C1552950:Grain [Quantitative Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.35: There are two genetic haplotype clades in Caucasian populations, designated H1 and H2, which differ in intron sizes, promoter sequence and wobble bases (19). 

Phrase: "There"

Phrase: "are"

Phrase: "two genetic haplotype clades in Caucasian populations,"

Phrase: "designated H1"

Phrase: "and"

Phrase: "H2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0919509:H2 [Gene or Genome]
  1000   C1419394:H2 [Gene or Genome]

Phrase: "which"

Phrase: "differ in intron sizes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0456389:SIZES [Spatial Concept]

Phrase: "promoter sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "wobble bases"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   861   C0178499:bases [Chemical Viewed Functionally]
   861   C1626935:Bases [Quantitative Concept]
   827 E C0002055:base [Inorganic Chemical]
   827 E C1527178:Basis [Functional Concept]
   827 E C1874451:Basis [Pharmacologic Substance]
   827 E C1880279:Base [Biomedical or Dental Material]
   777 E C0205112:Basal [Spatial Concept]
   768 E C0016617:Foundation [Organization]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.36: The H1 haplotype has a frequency of 75% in Caucasians, and thus the H1 homozygotes constitute 60% of such populations. 

Phrase: "The H1 haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]

Phrase: "has"

Phrase: "a frequency of 75%"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0376249:frequency [Quantitative Concept]
   770   C0439603:Frequency [Temporal Concept]
   770   C0871396:Frequency [Quantitative Concept]
   770   C1561548:Frequency [Qualitative Concept]
   770   C1705502:Frequency [Quantitative Concept]

Phrase: "in Caucasians,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007457:Caucasians [Population Group]
  1000   C0043157:Caucasians [Population Group]

Phrase: "and"

Phrase: "thus"

Phrase: "the H1 homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "constitute"

Phrase: "60% of such populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032659:Population [Quantitative Concept]
   770   C1257890:Population [Population Group]
Processing 00000000.tx.37: However, individuals with one of the three sporadic tau diseases, progressive supranuclear palsy (19), corticobasal degeneration (20) and argyrophilic grain disease (21), although not Pick's disease (22) or Guam disease (23), show a robust association with H1 homozygosity, with a frequency of H1 homozygotes being 95%. 

Phrase: "However,"

Phrase: "individuals with one of the three sporadic tau diseases,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C0027361:Individual [Population Group]
   708   C0237401:Individual [Human]

Phrase: "progressive supranuclear palsy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "(19"

Phrase: ")"

Phrase: ","

Phrase: "corticobasal degeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0393570:Corticobasal degeneration [Disease or Syndrome]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: "(20"

Phrase: ")"

Phrase: "and"

Phrase: "argyrophilic grain disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0007757:Grain [Food]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0086369:Grain [Plant]
   827   C1552950:Grain [Quantitative Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "not Pick's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0236642:Pick's Disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C1707391:Pick [Activity]
   827   C1826583:PICK [Gene or Genome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(22"

Phrase: ")"

Phrase: "or"

Phrase: "Guam disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0543859:Guam Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a robust association with H1 homozygosity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "with a frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]

Phrase: "of H1 homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "being"

Phrase: "95%."
Processing 00000000.tx.38: These data show clearly that variability in either tau expression or tau splicing variability (or both) contribute to disease risk. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "clearly"

Phrase: "that variability in either tau expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C2827666:Variability [Conceptual Entity]
   748   C1868500:Variable expression [Finding]

Phrase: "or"

Phrase: "tau splicing variability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C2827666:Variability [Conceptual Entity]
   755 E C0439828:Variable [Qualitative Concept]

Phrase: "("

Phrase: "or"

Phrase: "both"

Phrase: ")"

Phrase: "contribute to disease risk."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C1281905:disease risk [Finding]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0035647:Risk [Qualitative Concept]
   770   C1880177:Contribute [Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.39: In this case, it is difficult to determine whether it is control of splicing or control of expression which is the key variable because it is indeed clear that many mutations which lead to Mendelian disease do so through altering alternate splicing (2,24). 

Phrase: "In this case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "it"

Phrase: "is"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "determine"

Phrase: "whether"

Phrase: "it"

Phrase: "is"

Phrase: "control of splicing"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0035687:Splicing [Genetic Function]
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C2610186:splicing [Genetic Function]
   790   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "control of expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "the key variable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:Variable [Qualitative Concept]

Phrase: "because"

Phrase: "it"

Phrase: "is"

Phrase: "indeed"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that"

Phrase: "many mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "which"

Phrase: "lead to Mendelian disease"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0012634:Disease [Disease or Syndrome]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "do"

Phrase: "so through altering alternate splicing"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0002345:Alternate Splicing [Genetic Function]
   760   C0035687:Splicing [Genetic Function]
   760   C0037640:SO [Geographic Area]
   760   C0332270:alternate [Functional Concept]
   760   C1523987:Alternate [Conceptual Entity]
   760   C2610186:splicing [Genetic Function]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.40: Parkinson's disease/Lewy body dementia Mutations in the -synuclein gene cause autosomal dominant Parkinson's disease, and -synuclein is the primary component of Lewy bodies, the pathognomic feature of Parkinson's disease (25). 

Phrase: "Parkinson's disease/Lewy body dementia Mutations in the -synuclein gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   757   C0596611:gene mutations [Genetic Function]
   739   C0026882:Mutations [Genetic Function]
   706 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "autosomal dominant Parkinson's disease,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C3489791:Parkinson Disease, Autosomal Dominant [Disease or Syndrome]
   861   C0030567:Parkinson Disease [Disease or Syndrome]
   861   C1521736:Parkinson's Disease [Functional Concept]
   861   C2681933:PARKINSON DISEASE [Gene or Genome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
   712   C1021144:Parkinsonia [Plant]

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "the primary component of Lewy bodies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "the pathognomic feature of Parkinson's disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1521970:Feature [Qualitative Concept]
   753   C1706388:Feature [Conceptual Entity]
   753   C2346469:Feature [Qualitative Concept]
   753   C2348519:Feature [Qualitative Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.41: Genetic variability in the -synuclein promoter contributes to the risk of sporadic Parkinson's disease (26,27) with the associated promoter allele being a stronger promoter (28). 

Phrase: "Genetic variability in the -synuclein promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2827666:Variability [Conceptual Entity]

Phrase: "contributes to the risk of sporadic Parkinson's disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0030567:Parkinson Disease [Disease or Syndrome]
   770   C1521736:Parkinson's Disease [Functional Concept]
   770   C2681933:PARKINSON DISEASE [Gene or Genome]
   767   C1281905:disease risk [Finding]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0035647:Risk [Qualitative Concept]
   744   C0205422:Sporadic [Temporal Concept]
   744   C1880177:Contribute [Activity]

Phrase: "(26,"

Phrase: "27"

Phrase: ")"

Phrase: "with the associated promoter allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "being"

Phrase: "a stronger promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.42: Perhaps most convincingly, triplication of the whole -synuclein locus causes autosomal dominant Parkinson's disease/Lewy body dementia with an onset age in the fourth decade (29) and duplication of the locus leads to disease in the fifth decade (30). 

Phrase: "Perhaps most convincingly,"

Phrase: "triplication of the whole -synuclein locus"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "autosomal dominant Parkinson's disease/Lewy body dementia with an onset age"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   797   C0030567:parkinson disease lewy body [Disease or Syndrome]
   775   C0752347:Dementia, Lewy Body [Disease or Syndrome]
           Lewy Body Disease
           Dementia with Lewy bodies
   775   C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   772   C0349081:dementia parkinson's disease [Disease or Syndrome]
   756   C0085200:Lewy Body [Cell Component]
   738   C0011265:dementia [Mental or Behavioral Dysfunction]
   738   C0242821:body [Human]
   738   C0460148:Body [Anatomical Structure]
   738   C0497327:Dementia [Mental or Behavioral Dysfunction]
   738   C1268086:Body [Anatomical Structure]

Phrase: "in the fourth decade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2981279:Decade [Quantitative Concept]

Phrase: "(29"

Phrase: ")"

Phrase: "and"

Phrase: "duplication of the locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332597:Duplication [Functional Concept]
   770   C1705960:Duplication [Cell or Molecular Dysfunction]

Phrase: "leads to disease"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0012634:Disease [Disease or Syndrome]
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0181586:leads [Medical Device]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]

Phrase: "in the fifth decade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2981279:Decade [Quantitative Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.43: Thus, with Parkinson's disease, there is a clear dose relationship between synuclein expression and disease occurrence, with normal genetic variability in the promoter contributing to the risk of typical idiopathic disease and with multiplications of the locus causing Mendelian disease with an onset age determined by the precise dose. 

Phrase: "Thus,"

Phrase: "with Parkinson's disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "there"

Phrase: "is"

Phrase: "a clear dose relationship between synuclein expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "disease occurrence,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243132:occurrence [Functional Concept]
   861   C1554210:occurrence [Idea or Concept]
   861   C2745955:Occurrence [Temporal Concept]

Phrase: "with normal genetic variability"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C2827666:Variability [Conceptual Entity]
   755 E C0439828:Variable [Qualitative Concept]
   706   C0269694:Normal birth [Therapeutic or Preventive Procedure]
   706   C1384485:Normal birth [Finding]

Phrase: "in the promoter contributing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880177:Contributing [Activity]

Phrase: "to the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "of typical idiopathic disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0277553:Idiopathic disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0332240:Idiopathic [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "and with multiplications of the locus causing Mendelian disease"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   745   C1314792:disease cause [Functional Concept]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0678227:Causing [Functional Concept]
   742   C1515981:And [Idea or Concept]
   742   C1708726:Locus [Gene or Genome]
   708 E C0015127:cause [Functional Concept]
   708 E C1524003:Cause [Conceptual Entity]
   708   C2911648:Multiplication [Quantitative Concept]

Phrase: "with an onset age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206132:Onset Age [Quantitative Concept]
   861   C0001779:Age [Organism Attribute]

Phrase: "determined by the precise dose."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0178602:Dose [Quantitative Concept]
   760   C0869039:Dose [Quantitative Concept]
   760   C1114758:Dose # [Clinical Attribute]
   760   C2939802:Precise [Pharmacologic Substance]
Processing 00000000.tx.44: Protein studies in cell lines from affected individuals in these kindreds reveal that the amount of -synuclein produced correlates with disease (A. Singleton et al., unpublished data; 31).  

Phrase: "Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "in cell lines from affected individuals"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0007600:Cell lines [Cell]
   753   C0205132:lines [Spatial Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "in these kindreds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598429:kindreds [Qualitative Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "that"

Phrase: "the amount of -synuclein produced correlates with disease"

Phrase: "(A. Singleton et al.,"

Phrase: "unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "; 31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.45: METHODOLOGICAL CONSIDERATIONS TOP ABSTRACT INTRODUCTION THE DISEASES METHODOLOGICAL CONSIDERATIONS CONCLUSIONS AND PREDICTIONS REFERENCES  The problems of the assessment of haplotypic expression Rigorous assessment of the impact of haplotypic variation on quantitative gene expression and splicing is a surprisingly difficult problem (32). 

Phrase: "METHODOLOGICAL CONSIDERATIONS TOP ABSTRACT INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1293116:Introduction [Health Care Activity]
   804   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "THE DISEASES METHODOLOGICAL CONSIDERATIONS CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1707478:Conclusions [Idea or Concept]

Phrase: "AND"

Phrase: "PREDICTIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681842:predictions [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The problems of the assessment of haplotypic expression Rigorous assessment of the impact"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   735   C1546466:Problems [Idea or Concept]
   702 E C0033213:Problem [Finding]

Phrase: "of haplotypic variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variation [Qualitative Concept]

Phrase: "on quantitative gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017262:Gene Expression [Genetic Function]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]

Phrase: "is"

Phrase: "a surprisingly difficult problem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033213:Problem [Finding]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.46: The usual method to test variability in the control of expression is to tie an artificial and arbitrary reporter construct to a bacterially-derived reporter gene and measure its transient effect on expression in a tumor-derived cell line. 

Phrase: "The usual method to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "variability in the control of expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C2827666:Variability [Conceptual Entity]
   748   C0683951:control variable [Quantitative Concept]
   748   C1868500:Variable expression [Finding]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "tie"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453920:Tie [Manufactured Object]
  1000   C3472712:Tie [Manufactured Object]

Phrase: "an artificial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2004457:Artificial [Qualitative Concept]

Phrase: "and"

Phrase: "arbitrary reporter construct to a bacterially-derived reporter gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "its transient effect on expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "in a tumor-derived cell line."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   923   C0085983:Cell Line, Tumor [Cell]
   875   C0431085:Tumor cell [Cell]
   875   C0597032:Tumor Cell [Cell]
   861   C0007600:Cell Line [Cell]
   861   C1519667:Tumor-Derived [Functional Concept]
   812   C0007634:Cell [Cell]
   812   C0027651:Tumor [Neoplastic Process]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1441547:Derived [Qualitative Concept]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1578706:Tumor [Intellectual Product]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   812   C3245521:derived [Idea or Concept]
   812   C3273930:Tumor [Finding]
Processing 00000000.tx.47: Clearly such experiments are unlikely to yield data of direct relevance to subtle effects of variation on gene expression. 

Phrase: "Clearly"

Phrase: "such experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "are"

Phrase: "unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "yield"

Phrase: "data of direct relevance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "to subtle effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "of variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:Variation [Qualitative Concept]

Phrase: "on gene expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.48: The development of allele-specific gene expression methods (33,34) offers hope that more subtle effects can be studied although these methods are arduous and require access to large numbers of well-maintained human brain specimens (33).  

Phrase: "The development of allele-specific gene expression methods"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   750   C0178742:method development [Intellectual Product]
   744   C0243107:development [Physiologic Function]
   744   C0678723:Development [Organism Function]
   744   C1527148:Development [Functional Concept]
   731   C0017340:Gene, Developmental [Gene or Genome]

Phrase: "(33,"

Phrase: "34"

Phrase: ")"

Phrase: "offers"

Phrase: "hope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392347:Hope [Mental Process]

Phrase: "that more subtle effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "although"

Phrase: "these methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "are"

Phrase: "arduous"

Phrase: "and"

Phrase: "require"

Phrase: "access to large numbers of well-maintained human brain specimens"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0444454:Access [Spatial Concept]
   739   C1554204:access [Idea or Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.49: CONCLUSIONS AND PREDICTIONS TOP ABSTRACT INTRODUCTION THE DISEASES METHODOLOGICAL CONSIDERATIONS CONCLUSIONS AND PREDICTIONS REFERENCES  In all the diseases referred to above, there is thus strong evidence that, while frank mutations in the pathologic locus cause autosomal dominant disease and protein deposition, genetic variability in expression of the normal protein contributes to the risk of idiopathic disease. 

Phrase: "CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusions [Idea or Concept]

Phrase: "AND"

Phrase: "PREDICTIONS TOP ABSTRACT INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1293116:Introduction [Health Care Activity]
   812   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "THE DISEASES METHODOLOGICAL CONSIDERATIONS CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1707478:Conclusions [Idea or Concept]

Phrase: "AND"

Phrase: "PREDICTIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681842:predictions [Idea or Concept]

Phrase: "REFERENCES  In all"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1514811:Reference [Idea or Concept]
   790   C1706462:Reference [Conceptual Entity]

Phrase: "the diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "referred to above, there"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1555599:Referred to [Idea or Concept]
   833   C1691010:Referred to [Functional Concept]
           Referred
   770   C0205543:referred [Functional Concept]

Phrase: "is"

Phrase: "thus strong evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332120:Evidence [Functional Concept]

Phrase: "that,"

Phrase: "while"

Phrase: "frank mutations in the pathologic locus"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "autosomal dominant disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   734   C0443147:Autosomal dominant [Intellectual Product]

Phrase: "and"

Phrase: "protein deposition,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0333584:Protein deposition [Pathologic Function]
   861   C0333562:Deposition [Functional Concept]

Phrase: "genetic variability in expression of the normal protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C2827666:Variability [Conceptual Entity]
   731   C1868500:Variable expression [Finding]

Phrase: "contributes to the risk of idiopathic disease."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0277553:Idiopathic disease [Disease or Syndrome]
   774   C1281905:disease risk [Finding]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0035647:Risk [Qualitative Concept]
   748   C0332240:Idiopathic [Functional Concept]
   748   C1880177:Contribute [Activity]
Processing 00000000.tx.50: In Alzheimer's disease, where the deposited protein is a peptide fragment of the primary locus, mutations in the cleaving enzyme also lead to disease. 

Phrase: "In Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "where"

Phrase: "the deposited protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a peptide fragment of the primary locus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0030935:peptide fragment [Amino Acid, Peptide, or Protein]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0332255:fragment [Functional Concept]
   748   C1708096:Fragment [Qualitative Concept]

Phrase: "mutations in the cleaving enzyme also"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "lead to disease."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0012634:Disease [Disease or Syndrome]
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.51: These simple observations lead to some predictions: the mutant and wild-type proteins are quantitatively different, not qualitatively different in their properties in all cases; 

Phrase: "These simple observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "lead to some predictions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0681842:predictions [Idea or Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "the mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "wild-type proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "are"

Phrase: "quantitatively different,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]

Phrase: "not qualitatively different in their properties"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "in all cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.52: in other diseases where protein deposition is part of the process, such as the polyglutamine diseases and ALS, genetic variability in the promoter of the gene should be considered as a factor influencing, where applicable, risk of sporadic disease or age of onset of familial disease (see 35 for suggestions that this might also be the case in Huntington's disease); 

Phrase: "in other diseases where protein deposition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333584:Protein deposition [Pathologic Function]
   812   C0333562:Deposition [Functional Concept]

Phrase: "is"

Phrase: "part of the process,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1292711:Part of [Spatial Concept]
   770   C0449719:Part [Spatial Concept]
   770   C1709471:Part [Quantitative Concept]

Phrase: "such as the polyglutamine diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "ALS,"

Phrase: "genetic variability in the promoter of the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2827666:Variability [Conceptual Entity]

Phrase: "should"

Phrase: "be"

Phrase: "considered as a factor influencing,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0960756:factor A [Organic Chemical]
   760   C0750591:considered [Idea or Concept]
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]

Phrase: "where applicable, risk of sporadic disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1281905:disease risk [Finding]
   753   C0035647:Risk [Qualitative Concept]

Phrase: "or"

Phrase: "age of onset of familial disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   753   C0001779:Age [Organism Attribute]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "35 for suggestions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0038659:Suggestions [Idea or Concept]
   756 E C1705535:suggestion [Idea or Concept]

Phrase: "that"

Phrase: "this"

Phrase: "might"

Phrase: "also"

Phrase: "be"

Phrase: "the case in Huntington's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0868928:Case [Functional Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.53: in polyglutamine diseases in which the deposited fragment is cleaved from a precursor molecule, genetic variability in the cleaving proteases or other interactors which influence stability should be assessed as a risk factor loci; 

Phrase: "in polyglutamine diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "in which"

Phrase: "the deposited fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "is"

Phrase: "cleaved from a precursor molecule,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205242:Cleaved [Spatial Concept]
   760   C0333853:Cleaved [Cell]
   760   C0567416:Molecule [Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "genetic variability in the cleaving proteases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2827666:Variability [Conceptual Entity]

Phrase: "or"

Phrase: "other interactors"

Phrase: "which"

Phrase: "influence"

Phrase: "stability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205360:Stability [Qualitative Concept]
  1000   C2347098:Stability [Qualitative Concept]
   928 E C1547311:Stable [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "assessed as a risk factor loci"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0035648:Risk factor [Quantitative Concept]
   783   C0960756:factor A [Organic Chemical]
   753   C0035647:Risk [Qualitative Concept]
   753   C1516048:Assessed [Activity]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]
   719   C1708726:Locus [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.54: other loci which impact on risk for these diseases in general, may merely cause their effect through altering the levels of the primary proteins, either because they are transcription factors, or because they are responsible for protein breakdown. 

Phrase: "other loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]

Phrase: "which impact on risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1825598:IMPACT [Gene or Genome]

Phrase: "for these diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "in general,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]

Phrase: "may"

Phrase: "merely"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "their effect through altering"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "the levels of the primary proteins,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0441889:Levels [Qualitative Concept]
   750   C0428479:Protein level [Laboratory or Test Result]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "either"

Phrase: "because"

Phrase: "they"

Phrase: "are"

Phrase: "transcription factors,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "or"

Phrase: "because"

Phrase: "they"

Phrase: "are"

Phrase: "responsible for protein breakdown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]
Processing 00000000.tx.55: While these findings were unexpected, perhaps they should not have been. 

Phrase: "While"

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "were"

Phrase: "unexpected, perhaps"

Phrase: "they"

Phrase: "should"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "been."
Processing 00000000.tx.56: All chemists know the power of the law of mass action, and perhaps it should not have surprised us that it may have profound implications in determining our risks of neurodegenerative disease (36). 

Phrase: "All chemists"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0334707:CHEMISTS [Professional or Occupational Group]

Phrase: "know"

Phrase: "the power of the law of mass action,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "and"

Phrase: "perhaps"

Phrase: "it"

Phrase: "should"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "surprised"

Phrase: "us"

Phrase: "that"

Phrase: "it"

Phrase: "may"

Phrase: "have"

Phrase: "profound implications in determining"

Phrase: "our risks of neurodegenerative disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risks [Finding]
   760   C0035647:Risks [Qualitative Concept]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.57: Of course, one therapeutic approach in all cases, therefore, would be to aim to reduce the concentrations of the toxic proteins in the relevant tissue compartment either through decreased production, increased breakdown, or both.  

Phrase: "Of course,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750729:Course [Temporal Concept]

Phrase: "one therapeutic approach in all cases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449445:Approach [Spatial Concept]

Phrase: "therefore,"

Phrase: "would"

Phrase: "be"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "aim"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1947946:Aim [Idea or Concept]
  1000   C2948600:Aim [Pharmacologic Substance]
  1000   C3540471:AIM [Gene or Genome]
  1000   C3540472:AIM [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "the concentrations of the toxic proteins"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0086045:Concentrations [Mental Process]
   750   C0427716:Protein concentration [Laboratory Procedure]
   750   C1304757:Protein concentration [Laboratory or Test Result]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "in the relevant tissue compartment either"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1185625:Compartment [Body Space or Junction]
   812   C2986730:Compartment [Spatial Concept]

Phrase: "through decreased production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "increased breakdown,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0443161:break down [Qualitative Concept]
   861   C0699900:breakdown [Organism Function]
   861   C1265875:breakdown [Acquired Abnormality]

Phrase: "or"

Phrase: "both."
Processing 00000000.tx.58: ACKNOWLEDGEMENTS  This work was supported by the NIA/NIH intramural programme.  

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by the NIA/NIH intramural programme."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C1512961:Intramural Program [Health Care Related Organization]
   748   C0027468:NIH [Health Care Related Organization]
   748   C0205102:Intramural [Spatial Concept]
   748   C1074110:Nia [Fungus]
   748   C1521721:Supported [Conceptual Entity]
   748   C1709697:Program [Conceptual Entity]
   748   C1955974:NIA [Health Care Related Organization]
   748   C2728259:Program [Pharmacologic Substance]
   748   C3484370:Program [Functional Concept]
   714 E C0183683:Support [Medical Device]
Processing 00000000.tx.59: FOOTNOTES  * To whom correspondence should be addressed. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.60: Tel: +1 3014513829; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+1 3014513829"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.61: Fax: +1 3014800335; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+1 3014800335"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.62: Email: hardyj{at}mail.nih.gov  REFERENCES TOP ABSTRACT INTRODUCTION THE DISEASES METHODOLOGICAL CONSIDERATIONS CONCLUSIONS AND PREDICTIONS REFERENCES  Owen, F., Poulter, M., Lofthouse, R., Collinge, J., Crow, T.J., Risby, D., Baker, H.F., Ridley, R.M., Hsiao, K. and Prusiner, S.B. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "hardyj{at}mail.nih.gov"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1419208:GOV [Gene or Genome]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1293116:Introduction [Health Care Activity]
   827   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "THE DISEASES METHODOLOGICAL CONSIDERATIONS CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1707478:Conclusions [Idea or Concept]

Phrase: "AND"

Phrase: "PREDICTIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681842:predictions [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Owen,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Poulter,"

Phrase: "M."

Phrase: ","

Phrase: "Lofthouse,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Collinge,"

Phrase: "J.,"

Phrase: "Crow,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0326391:Crow [Bird]
  1000   C1551958:Crow [Language]
  1000   C1555179:Crow [Population Group]

Phrase: "T.J.,"

Phrase: "Risby,"

Phrase: "D."

Phrase: ","

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "H.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Ridley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "M."

Phrase: ","

Phrase: "Hsiao,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Prusiner,"

Phrase: "S."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.63: (1989) Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Insertion in prion protein gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1955829:Gene Insertion [Cell or Molecular Dysfunction]
   760   C0021107:Insertion [Therapeutic or Preventive Procedure]
   760   C0441587:Insertion [Health Care Activity]
   760   C1512796:Insertion [Genetic Function]
   760   C1883719:Insertion [Functional Concept]

Phrase: "in familial Creutzfeldt-Jakob disease."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0751254:Creutzfeldt-Jakob Disease, Familial [Disease or Syndrome]
   923   C0022336:Creutzfeldt-Jakob disease [Disease or Syndrome]
   923   C1418941:CREUTZFELDT-JAKOB DISEASE [Gene or Genome]
   902   C0277558:Familial disease [Disease or Syndrome]
   867 E C0344339:family disease [Finding]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.64: Lancet, 1, 5152.[CrossRef] Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover A. et al. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "5152."

Phrase: "[CrossRef"

Phrase: "] Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Lendon,"

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Rizzu,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Froelich,"

Phrase: "S."

Phrase: ","

Phrase: "Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Pickering-Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "S."

Phrase: ","

Phrase: "Chakraverty,"

Phrase: "S."

Phrase: ","

Phrase: "Isaacs,"

Phrase: "A.,"

Phrase: "Grover A. et al."
Processing 00000000.tx.65: (1998) Coding and splice donor site mutations in tau cause autosomal dominant dementia (FTDP-17). 

Phrase: "(1998"

Phrase: ")"

Phrase: "Coding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009219:Coding [Occupational Activity]

Phrase: "and"

Phrase: "splice donor site mutations in tau"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0887917:Splice Donor Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   809   C1519478:Splice-Site Mutation [Genetic Function]
   790   C1444716:Donor site [Body Location or Region]
   753   C0013018:Donor [Population Group]
   753   C0026882:Mutations [Genetic Function]
   753   C0040288:Donor [Population Group]
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C1527169:Donor NOS [Finding]
   753   C2825164:Site [Spatial Concept]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "autosomal dominant dementia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   734   C0443147:Autosomal dominant [Intellectual Product]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "(FTDP-17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0338451:FTDP-17 [Disease or Syndrome]
  1000   C1446659:FTDP-17 [Gene or Genome]
  1000   C2697954:FTDP-17 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.66: Nature, 393, 702705.[CrossRef][Medline] Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. et al. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "393,"

Phrase: "702705."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Polymeropoulos,"

Phrase: "M."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lavedan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Root,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040452:Root [Body Part, Organ, or Organ Component]
  1000   C0242726:Root [Plant]
  1000   C1318154:Root [Body Part, Organ, or Organ Component]
  1000   C1705917:Root [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rubenstein,"

Phrase: "J.,"

Phrase: "Boyer,"

Phrase: "R. et al."
Processing 00000000.tx.67: (1997) Mutation in the a-synuclein gene identified in families with Parkinson's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mutation in the a-synuclein gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0596611:Gene Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified in families"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0015576:Families [Family Group]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   790   C1704727:Family [Conceptual Entity]
   706 E C0241888:Familial [Functional Concept]

Phrase: "with Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.68: Science, 276, 20452047.[Abstract/Free FullText] Rogaeva, E. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "276,"

Phrase: "20452047."

Phrase: "[Abstract/Free FullText"

Phrase: "] Rogaeva,"

Phrase: "E."
Processing 00000000.tx.69: (2002) The solved and unsolved mysteries of the genetics of early-onset Alzheimer's disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "The solved"

Phrase: "and"

Phrase: "unsolved mysteries of the genetics of early-onset Alzheimer's disease."
Processing 00000000.tx.70: Neuromol. 

Phrase: "Neuromol."
Processing 00000000.tx.71: Med., 2, 110.[CrossRef] Takasugi, N., Tomita, T., Hayashi, I., Tsuruoka, M., Niimura, M., Takahashi, Y., Thinakaran, G. and Iwatsubo, T. 

Phrase: "Med.,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "110."

Phrase: "[CrossRef"

Phrase: "] Takasugi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hayashi,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Tsuruoka,"

Phrase: "M."

Phrase: ","

Phrase: "Niimura,"

Phrase: "M."

Phrase: ","

Phrase: "Takahashi,"

Phrase: "Y.,"

Phrase: "Thinakaran,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.72: (2003) The role of presenilin cofactors in the gamma-secretase complex. 

Phrase: "(2003"

Phrase: ")"

Phrase: "The role of presenilin cofactors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the gamma-secretase complex."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2753842:gamma-secretase complex [Cell Component]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]
   734   C0379528:gamma-Secretase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.73: Nature, 422, 438441.[CrossRef][Medline] Edbauer, D., Winkler E., Regula, J.T., Pesold, B., Steiner, H. and Haass, C. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "422,"

Phrase: "438441."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Edbauer,"

Phrase: "D."

Phrase: ","

Phrase: "Winkler E.,"

Phrase: "Regula,"

Phrase: "J.T.,"

Phrase: "Pesold,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Steiner,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.74: (2003) Reconstitution of gamma-secretase activity. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Reconstitution of gamma-secretase activity."
Processing 00000000.tx.75: Nat. 

Phrase: "Nat."
Processing 00000000.tx.76: Cell Biol., 5, 486488.[CrossRef][Medline] Hardy, J. and Gwinn-Hardy, K. 

Phrase: "Cell Biol.,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "486488."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hardy,"

Phrase: "J."

Phrase: "and"

Phrase: "Gwinn-Hardy,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.77: (1998) Genetic classification of primary neurodegenerative disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Genetic classification of primary neurodegenerative disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0683326:classification disease [Intellectual Product]
   753   C0008902:Classification [Classification]
   753   C0008903:classification [Functional Concept]
   753   C0678229:classification [Occupational Activity]
Processing 00000000.tx.78: Science, 282, 10751079.[Abstract/Free FullText] Klein, W.L. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "282,"

Phrase: "10751079."

Phrase: "[Abstract/Free FullText"

Phrase: "] Klein,"

Phrase: "W.L."
Processing 00000000.tx.79: (2002) ADDLs and protofibrils-the missing links? 

Phrase: "(2002"

Phrase: ")"

Phrase: "ADDLs"

Phrase: "and"

Phrase: "protofibrils-"

Phrase: "the missing links?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]
Processing 00000000.tx.80: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.81: Aging, 23, 231235.[CrossRef][Medline] Palmer, M.S., Dryden, A.J., Hughes, J.T. and Collinge, J. 

Phrase: "Aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "231235."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Palmer,"

Phrase: "M.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Dryden,"

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "Hughes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551730:Hughes [Population Group]

Phrase: "J.T."

Phrase: "and"

Phrase: "Collinge,"

Phrase: "J."
Processing 00000000.tx.82: (1991) Homozygous prion protein genotype predisposes to sporadic CreutzfeldtJakob disease. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Homozygous prion protein genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C0019904:homozygous genotype [Organism Attribute]
   812   C0017431:Genotype [Organism Attribute]

Phrase: "predisposes to sporadic CreutzfeldtJakob disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0012634:Disease [Disease or Syndrome]
   760   C0205422:Sporadic [Temporal Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.83: Nature, 352, 340342.[CrossRef][Medline] Collinge, J., Palmer, M.S. and Dryden, A.J. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "352,"

Phrase: "340342."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Collinge,"

Phrase: "J.,"

Phrase: "Palmer,"

Phrase: "M.S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Dryden,"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]
Processing 00000000.tx.84: (1991) Genetic predisposition to iatrogenic CreutzfeldtJakob disease. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Genetic predisposition to iatrogenic CreutzfeldtJakob disease."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   864   C0314657:Genetic Predisposition to Disease [Organism Attribute]
           Genetic Predisposition
   783   C0019247:Genetic disease [Disease or Syndrome]
   753   C0012655:Predisposition [Clinical Attribute]
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0220898:Predisposition [Organism Attribute]
   753   C0314603:Genetic [Functional Concept]
   742 E C2316203:Genetic diseases [Finding]
   742 E C2924406:Genetic diseases [Laboratory Procedure]
Processing 00000000.tx.85: Lancet, 337, 14411442.[CrossRef][Medline] Mead, S., Mahal, S.P., Beck, J., Campbell, T., Farrall, M., Fisher, E. and Collinge, J. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "337,"

Phrase: "14411442."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mead,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678406:mead [Food]

Phrase: "S."

Phrase: ","

Phrase: "Mahal,"

Phrase: "S.P.,"

Phrase: "Beck,"

Phrase: "J.,"

Phrase: "Campbell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331936:Campbell [Health Care Related Organization]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Farrall,"

Phrase: "M."

Phrase: ","

Phrase: "Fisher,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325045:Fisher [Mammal]

Phrase: "E."

Phrase: "and"

Phrase: "Collinge,"

Phrase: "J."
Processing 00000000.tx.86: (2001) Sporadic but not variant CreutzfeldtJakob disease is associated with polymorphisms upstream of PRNP exon 1. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Sporadic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205422:Sporadic [Temporal Concept]

Phrase: "but"

Phrase: "not variant CreutzfeldtJakob disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "associated with polymorphisms"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0032529:polymorphisms [Genetic Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   756 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "upstream of PRNP exon 1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1418941:PRNP [Gene or Genome]
Processing 00000000.tx.87: Am. 

Phrase: "Am."
Processing 00000000.tx.88: J. 

Phrase: "J."
Processing 00000000.tx.89: Hum. 

Phrase: "Hum."
Processing 00000000.tx.90: Genet., 69, 12251235.[CrossRef][Medline] Bueler, H., Aguzzi, A., Sailer, A., Greiner, R.A., Autenried, P., Aguet, M. and Weissmann. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "12251235."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bueler,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Aguzzi,"

Phrase: "A.,"

Phrase: "Sailer,"

Phrase: "A.,"

Phrase: "Greiner,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "Autenried,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Aguet,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Weissmann."
Processing 00000000.tx.91: C. 

Phrase: "C."
Processing 00000000.tx.92: (1993) Mice devoid of PrP are resistant to scrapie. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "devoid of PrP"

Phrase: "are"

Phrase: "resistant to scrapie."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036457:Scrapie [Disease or Syndrome]
   734   C0332325:Resistant to [Functional Concept]
Processing 00000000.tx.93: Cell, 73, 13391347.[Medline] Liddell, M.B., Bayer, A.J. and Owen, M.J. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "73,"

Phrase: "13391347."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Liddell,"

Phrase: "M.B.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bayer,"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "and"

Phrase: "Owen,"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.94: (1995) No evidence that common allelic variation in the amyloid precursor protein (APP) gene confers susceptibility to Alzheimer's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "No evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that common allelic variation in the amyloid precursor protein (APP) gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205419:Variation [Qualitative Concept]

Phrase: "confers"

Phrase: "susceptibility to Alzheimer's disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0012655:Disease susceptibility [Clinical Attribute]
           Susceptibility
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]
Processing 00000000.tx.95: Hum. 

Phrase: "Hum."
Processing 00000000.tx.96: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.97: Genet., 4, 853858.[Abstract] Wavrant-De Vrieze, F., Crook, R., Holmans, P., Kehoe, P., Owen, M.J., Williams, J., Roehl, K., Lahiri, D.K., Shears, S., Booth, J. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "4,"

Phrase: "853858."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Wavrant-De Vrieze,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Holmans,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kehoe,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Owen,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Williams,"

Phrase: "J.,"

Phrase: "Roehl,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lahiri,"

Phrase: "D."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Shears,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0175735:shears [Medical Device]
   966 E C0205013:shear [Therapeutic or Preventive Procedure]

Phrase: "S."

Phrase: ","

Phrase: "Booth,"

Phrase: "J. et al."
Processing 00000000.tx.98: (1999) Genetic variability at the amyloid-beta precursor protein locus may contribute to the risk of late onset Alzheimer's disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Genetic variability at the amyloid-beta precursor protein locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2827666:Variability [Conceptual Entity]

Phrase: "may"

Phrase: "contribute to the risk of late onset Alzheimer's disease."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   818   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   781   C0814122:late disease onset [Finding]
   764   C0002395:Alzheimer's Disease [Disease or Syndrome]
   764   C1521724:Alzheimer's Disease [Pathologic Function]
   762   C0277793:disease onset [Temporal Concept]
   762   C1281905:disease risk [Finding]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0035647:Risk [Qualitative Concept]
   742   C0205087:Late [Temporal Concept]
   742   C0332162:Onset [Qualitative Concept]
   742   C1880177:Contribute [Activity]
Processing 00000000.tx.99: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.100: Lett., 269, 6770.[CrossRef][Medline] Olson, J.M., Goddard, K.A. and Dudek, D.M. 

Phrase: "Lett.,"

Phrase: "269,"

Phrase: "6770."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Olson,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Goddard,"

Phrase: "K.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Dudek,"

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.101: (2001) The amyloid precursor protein locus and very-late-onset Alzheimer disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "The amyloid precursor protein locus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1708726:Locus [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "very-late-onset Alzheimer disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   937   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   804   C0012634:Disease [Disease or Syndrome]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.102: Am. 

Phrase: "Am."
Processing 00000000.tx.103: J. 

Phrase: "J."
Processing 00000000.tx.104: Hum. 

Phrase: "Hum."
Processing 00000000.tx.105: Genet., 69, 895899.[CrossRef][Medline] Olson, M.I. and Shaw, C.M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "895899."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Olson,"

Phrase: "M.I."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Shaw,"

Phrase: "C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.106: (1969) Presenile dementia and Alzheimer's disease in mongolism. 

Phrase: "(1969"

Phrase: ")"

Phrase: "Presenile dementia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0011265:Pre-senile dementia [Mental or Behavioral Dysfunction]
           dementia
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "Alzheimer's disease in mongolism."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.107: Brain, 92, 147156.[Medline] Prasher, V.P., Farrer, M.J., Kessling, A.M., Fisher, E.M., West, R.J., Barber, P.C. and Butler, A.C. 

Phrase: "Brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "92,"

Phrase: "147156."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Prasher,"

Phrase: "V.P.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1535597:v p [Therapeutic or Preventive Procedure]

Phrase: "Farrer,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Kessling,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Fisher,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325045:Fisher [Mammal]

Phrase: "E.M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:West [Spatial Concept]

Phrase: "R.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Barber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335371:Barber [Professional or Occupational Group]

Phrase: "P.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Butler,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402644:Butler [Professional or Occupational Group]

Phrase: "A.C."
Processing 00000000.tx.108: (1998) Molecular mapping of Alzheimer-type dementia in Down's syndrome. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Molecular mapping of Alzheimer-type dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1283195:Mapping [Activity]

Phrase: "in Down's syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.109: Ann. 

Phrase: "Ann."
Processing 00000000.tx.110: Neurol., 43, 380383.[Medline] Spillantini, M.G. and Goedert, M. 

Phrase: "Neurol.,"

Phrase: "43,"

Phrase: "380383."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Spillantini,"

Phrase: "M."

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.111: (1998) Tau protein pathology in neurodegenerative diseases. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Tau protein pathology in neurodegenerative diseases."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0030664:Pathology [Biomedical Occupation or Discipline]
   753   C0205469:pathology [Functional Concept]
   753   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.112: Trends Neurosci., 21, 428433.[CrossRef][Medline] Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Prez-Tur, J., Hardy, J., Lynch, T., Bigio, E. and Hutton, M. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci.,"

Phrase: "21,"

Phrase: "428433."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Litvan,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Adamson,"

Phrase: "J.,"

Phrase: "Dickson,"

Phrase: "D."

Phrase: ","

Phrase: "Prez-Tur,"

Phrase: "J.,"

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Lynch,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bigio,"

Phrase: "E."

Phrase: "and"

Phrase: "Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.113: (1999) Association of an extended haplotype in the tau gene with progressive supranuclear palsy. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Association of an extended haplotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "in the tau gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "with progressive supranuclear palsy."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]
Processing 00000000.tx.114: Hum. 

Phrase: "Hum."
Processing 00000000.tx.115: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.116: Genet., 4, 711715.[CrossRef] Houlden, H., Baker, M., Morris, H.R., MacDonald, N., Pickering-Brown, S., Adamson, J., Lees, A.J., Rossor, M.N., Quinn, N.P., Kertesz, A. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "4,"

Phrase: "711715."

Phrase: "[CrossRef"

Phrase: "] Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Morris,"

Phrase: "H.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "MacDonald,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Pickering-Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "S."

Phrase: ","

Phrase: "Adamson,"

Phrase: "J.,"

Phrase: "Lees,"

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "Rossor,"

Phrase: "M."

Phrase: "N., Quinn,"

Phrase: "N.P.,"

Phrase: "Kertesz,"

Phrase: "A. et al."
Processing 00000000.tx.117: (2001) Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Corticobasal degeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0393570:Corticobasal degeneration [Disease or Syndrome]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: "and"

Phrase: "progressive supranuclear palsy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "a common tau haplotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotype [Organism Attribute]
Processing 00000000.tx.118: Neurology, 56, 17021706.[Abstract/Free FullText] Togo, T., Sahara, N., Yen, S.H., Cookson, N., Ishizawa, T., Hutton, M., de Silva, R., Lees, A. and Dickson, D.W. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "56,"

Phrase: "17021706."

Phrase: "[Abstract/Free FullText"

Phrase: "] Togo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040363:Togo [Geographic Area]
  1000   C3463953:Togo [Eukaryote]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sahara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205654:Sahara [Geographic Area]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Yen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555429:Yen [Quantitative Concept]

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Cookson,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ishizawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "de Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   789   C0144237:Silvan [Organic Chemical]
   768 E C0043217:Wood [Substance]
   768 E C0442548:Woods [Geographic Area]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lees,"

Phrase: "A."

Phrase: "and"

Phrase: "Dickson,"

Phrase: "D.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.119: (2002) Argyrophilic grain disease is a sporadic 4-repeat tauopathy. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Argyrophilic grain disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0007757:Grain [Food]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0086369:Grain [Plant]
   827   C1552950:Grain [Quantitative Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "a sporadic 4-repeat tauopathy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205341:Repeat [Functional Concept]
   812   C0949664:Tauopathy [Disease or Syndrome]
   812   C1547730:Repeat [Temporal Concept]
   812   C1705914:Repeat [Conceptual Entity]
Processing 00000000.tx.120: J. 

Phrase: "J."
Processing 00000000.tx.121: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.122: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.123: Neurol., 61, 547556.[Medline] Morris, H.R., Baker, M., Yasojima, K., Houlden, H., Khan, M.N., Wood, N.W., Hardy, J., Grossman, M., Trojanowski, J., Revesz, T. et al. 

Phrase: "Neurol.,"

Phrase: "61,"

Phrase: "547556."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Morris,"

Phrase: "H.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Yasojima,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Khan,"

Phrase: "M."

Phrase: "N., Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "N.W., Hardy,"

Phrase: "J.,"

Phrase: "Grossman,"

Phrase: "M."

Phrase: ","

Phrase: "Trojanowski,"

Phrase: "J.,"

Phrase: "Revesz,"

Phrase: "T. et al."
Processing 00000000.tx.124: (2002) Analysis of tau haplotypes in Pick's disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Analysis of tau haplotypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "in Pick's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0236642:Pick's Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C1707391:Pick [Activity]
   861   C1826583:PICK [Gene or Genome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.125: Neurology, 59, 443445.[Abstract/Free FullText] Prez-Tur, J., Buee, L., Morris, H.R., Waring, S.C., Onstead, L., Wavrant, De Vrieze, F., Crook, R., Buee-Scherrer, V., Hof, P.R., Petersen, R.C. et al. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "59,"

Phrase: "443445."

Phrase: "[Abstract/Free FullText"

Phrase: "] Prez-Tur,"

Phrase: "J.,"

Phrase: "Buee,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Morris,"

Phrase: "H.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Waring,"

Phrase: "S.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Onstead,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Wavrant,"

Phrase: "De Vrieze,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Buee-Scherrer,"

Phrase: "V.,"

Phrase: "Hof,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538150:HOF [Gene or Genome]

Phrase: "P.R.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205090:R- [Spatial Concept]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Petersen,"

Phrase: "R.C. et al."
Processing 00000000.tx.126: (1999) Neurodegenerative diseases of Guam: analysis of tau. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Neurodegenerative diseases of Guam"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   802   C0543859:Guam Disease [Disease or Syndrome]
   770   C0012634:Diseases [Disease or Syndrome]

Phrase: ":"

Phrase: "analysis of tau."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]
Processing 00000000.tx.127: Neurology, 53, 411413.[Abstract/Free FullText] Hutton, M. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "53,"

Phrase: "411413."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.128: (2000) Missing tau mutation identified. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Missing tau mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.129: Ann. 

Phrase: "Ann."
Processing 00000000.tx.130: Neurol., 47, 417418.[CrossRef][Medline] Spillantini, M.G. and Goedert, M. 

Phrase: "Neurol.,"

Phrase: "47,"

Phrase: "417418."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Spillantini,"

Phrase: "M."

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.131: (2000) The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. 

Phrase: "(2000"

Phrase: ")"

Phrase: "The alpha-synucleinopathies"

Phrase: ":"

Phrase: "Parkinson's disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "dementia with Lewy bodies,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "multiple system atrophy."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.132: Ann. 

Phrase: "Ann."
Processing 00000000.tx.133: NY Acad. 

Phrase: "NY Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.134: Sci., 920, 1627.[Abstract/Free FullText] Kruger, R., Vieira-Saecker, A.M., Kuhn, W., Berg, D., Muller, T., Kuhnl, N., Fuchs, G.A., Storch, A., Hungs, M., Woitalla, D. et al. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "920,"

Phrase: "1627."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kruger,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vieira-Saecker,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kuhn,"

Phrase: "W.,"

Phrase: "Berg,"

Phrase: "D."

Phrase: ","

Phrase: "Muller,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kuhnl,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Fuchs,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A.,"

Phrase: "Storch,"

Phrase: "A.,"

Phrase: "Hungs,"

Phrase: "M."

Phrase: ","

Phrase: "Woitalla,"

Phrase: "D. et al."
Processing 00000000.tx.135: (1999) Increased susceptibility to sporadic Parkinson's disease by a certain combined -synuclein/apolipoprotein E genotype. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Increased susceptibility to sporadic Parkinson's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0012655:Disease susceptibility [Clinical Attribute]
           Susceptibility
   753   C0220898:Susceptibility [Organism Attribute]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "by a certain combined -synuclein/apolipoprotein E genotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.136: Ann. 

Phrase: "Ann."
Processing 00000000.tx.137: Neurol., 45, 611617.[CrossRef][Medline] Farrer, M., Maraganore, D.M., Lockhart, P., Singleton, A., Lesnick, T.G., de Andrade, M., West, A., de Silva, R., Hardy, J. and Hernandez, D. 

Phrase: "Neurol.,"

Phrase: "45,"

Phrase: "611617."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Maraganore,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Lockhart,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.,"

Phrase: "Lesnick,"

Phrase: "T.G.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603360:T' [Clinical Attribute]

Phrase: "de Andrade,"

Phrase: "M."

Phrase: ","

Phrase: "West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:West [Spatial Concept]

Phrase: "A.,"

Phrase: "de Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   789   C0144237:Silvan [Organic Chemical]
   768 E C0043217:Wood [Substance]
   768 E C0442548:Woods [Geographic Area]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hardy,"

Phrase: "J."

Phrase: "and"

Phrase: "Hernandez,"

Phrase: "D."
Processing 00000000.tx.138: (2001) -Synuclein gene haplotypes are associated with Parkinson's disease. 

Phrase: "(2001"

Phrase: ") -"

Phrase: "Synuclein gene haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "are"

Phrase: "associated with Parkinson's disease."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.139: Hum. 

Phrase: "Hum."
Processing 00000000.tx.140: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.141: Genet., 10, 18471851.[Abstract/Free FullText] Chiba-Falek, O., Touchman, J.W. and Nussbaum, R.L. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "10,"

Phrase: "18471851."

Phrase: "[Abstract/Free FullText"

Phrase: "] Chiba-Falek,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Touchman,"

Phrase: "J.W."

Phrase: "and"

Phrase: "Nussbaum,"

Phrase: "R.L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.142: (2003) Functional analysis of intra-allelic variation at NACP-Rep1 in the -synuclein gene. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Functional analysis of intra-allelic variation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0558024:Functional analysis [Health Care Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "at NACP-Rep1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413394:REP-1 [Gene or Genome]

Phrase: "in the -synuclein gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.143: Hum. 

Phrase: "Hum."
Processing 00000000.tx.144: Genet., 113, 426431.[Medline] Singleton, A., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "113,"

Phrase: "426431."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.,"

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Johnson,"

Phrase: "J.,"

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.,"

Phrase: "Hague,"

Phrase: "S."

Phrase: ","

Phrase: "Kachergus,"

Phrase: "J.,"

Phrase: "Hulihan,"

Phrase: "M."

Phrase: ","

Phrase: "Peuralinna,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Nussbaum,"

Phrase: "R. et al."
Processing 00000000.tx.145: (2003) -Synuclein locus triplication causes Parkinson's disease. 

Phrase: "(2003"

Phrase: ") -"

Phrase: "Synuclein locus triplication"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.146: Science, 302, 841.[Free FullText] Farrer, M., Wang, D., Lincoln, S., Kachergus, J., Langston, W.J. and Dickson, D. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "302,"

Phrase: "841."

Phrase: "[Free FullText"

Phrase: "] Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Wang,"

Phrase: "D."

Phrase: ","

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Kachergus,"

Phrase: "J.,"

Phrase: "Langston,"

Phrase: "W.J."

Phrase: "and"

Phrase: "Dickson,"

Phrase: "D."
Processing 00000000.tx.147: (2003) Genomic multiplication of the alpha-synuclein gene in three kindreds with familial Lewy body disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Genomic multiplication of the alpha-synuclein gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2911648:Multiplication [Quantitative Concept]

Phrase: "in three kindreds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598429:kindreds [Qualitative Concept]

Phrase: "with familial Lewy body disease."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   923   C0752347:Lewy Body Disease [Disease or Syndrome]
   902   C0277558:Familial disease [Disease or Syndrome]
   867 E C0344339:family disease [Finding]
   861   C0085200:Lewy Body [Cell Component]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0242821:body [Human]
   812   C0460148:Body [Anatomical Structure]
   812   C1268086:Body [Anatomical Structure]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
   729 E C1995017:Bodies [Cell Component]
Processing 00000000.tx.148: American Society of Human Genetics. 

Phrase: "American Society of Human Genetics."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0020124:Human Genetics [Biomedical Occupation or Discipline]
   804   C0017398:Genetics [Biomedical Occupation or Discipline]
   804   C0017399:genetics [Biologic Function]
   804   C0037455:society [Organization]
   804   C0086418:Human [Human]
   804   C0596070:American [Population Group]
Processing 00000000.tx.149: Abstract 2227. 

Phrase: "Abstract 2227."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0000857:Abstract [Occupational Activity]
   861   C0600678:Abstract [Intellectual Product]
   861   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.150: El-Agnaf, O.M., Salem, S.A., Paleologou, K.E., Cooper, L.J., Fullwood, N.J., Gibson, M.J., Curran, M.D., Court, J.A., Mann, D.M., Ikeda S. et al. 

Phrase: "El-Agnaf,"

Phrase: "O.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439114:O NOS [Intellectual Product]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Salem,"

Phrase: "S.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Paleologou,"

Phrase: "K.E.,"

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "L.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Fullwood,"

Phrase: "N.J.,"

Phrase: "Gibson,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Curran,"

Phrase: "M.D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Court,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178572:court [Organization]

Phrase: "J."

Phrase: "A.,"

Phrase: "Mann,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Ikeda S. et al."
Processing 00000000.tx.151: (2003) -Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. 

Phrase: "(2003"

Phrase: ") -"

Phrase: "Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "implicated in Parkinson's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "present in extracellular biological fluids,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "human plasma."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0544357:Human plasma [Pharmacologic Substance]
   861   C0032105:Plasma [Body Substance]
   861   C0086418:Human [Human]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
Processing 00000000.tx.152: FASEB J., 17, 19451947.[Abstract/Free FullText] Hoogendoorn, B., Coleman, S.L., Guy, C.A., Smith, K., Bowen, T., Buckland, P.R. and O'Donovan, M.C. 

Phrase: "FASEB J.,"

Phrase: "17,"

Phrase: "19451947."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hoogendoorn,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Coleman,"

Phrase: "S.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Guy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018408:GUY [Geographic Area]

Phrase: "C."

Phrase: "A.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Bowen,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Buckland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551805:Buckland [Population Group]

Phrase: "P.R."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205090:R- [Spatial Concept]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "O'Donovan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "M.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.153: (2003) Functional analysis of human promoter polymorphisms. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Functional analysis of human promoter polymorphisms."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0558024:Functional analysis [Health Care Activity]
   767   C0796451:polymorphism analysis [Diagnostic Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
Processing 00000000.tx.154: Hum. 

Phrase: "Hum."
Processing 00000000.tx.155: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.156: Genet., 12, 22492254.[Abstract/Free FullText] Lambert, J.C., Prez-Tur, J., Dupire, M.J., Galasko, D., Mann, D., Amouyel, P., Hardy, J., Delacourte, A. and Chartier-Harlin, M.C. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "22492254."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "J.C., Prez-Tur,"

Phrase: "J.,"

Phrase: "Dupire,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Galasko,"

Phrase: "D."

Phrase: ","

Phrase: "Mann,"

Phrase: "D."

Phrase: ","

Phrase: "Amouyel,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Delacourte,"

Phrase: "A."

Phrase: "and"

Phrase: "Chartier-Harlin,"

Phrase: "M.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.157: (1997) Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Distortion of allelic expression of apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332482:Distortion [Anatomical Abnormality]
   748   C2919017:Distortion [Qualitative Concept]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.158: Hum. 

Phrase: "Hum."
Processing 00000000.tx.159: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.160: Genet., 6, 21512154.[Abstract/Free FullText] Yan, H., Yuan, W., Velculescu, V.E., Vogelstein, B. and Kinzler, K.W. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "6,"

Phrase: "21512154."

Phrase: "[Abstract/Free FullText"

Phrase: "] Yan,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yuan,"

Phrase: "W.,"

Phrase: "Velculescu,"

Phrase: "V.E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231963:V E [Laboratory or Test Result]

Phrase: "Vogelstein,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Kinzler,"

Phrase: "K.W."
Processing 00000000.tx.161: (2002) Allelic variation in human gene expression. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Allelic variation in human gene expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:Variation [Qualitative Concept]
Processing 00000000.tx.162: Science, 297, 1143.[Free FullText] Farrer, L.A., Cupples, L.A., Wiater, P., Conneally, P.M., Gusella, J.F. and Myers, R.H. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "297,"

Phrase: "1143."

Phrase: "[Free FullText"

Phrase: "] Farrer,"

Phrase: "L.A.,"

Phrase: "Cupples,"

Phrase: "L.A.,"

Phrase: "Wiater,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Conneally,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Gusella,"

Phrase: "J.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Myers,"

Phrase: "R.H."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0205090:R- [Spatial Concept]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.163: (1993) The normal Huntington disease (HD) allele, or a closely linked gene, influences age at onset of HD. 

Phrase: "(1993"

Phrase: ")"

Phrase: "The normal Huntington disease (HD) allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: "or"

Phrase: "a closely linked gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0314613:Linked gene [Genetic Function]
   827   C0017337:Gene [Gene or Genome]

Phrase: "influences"

Phrase: "age at onset of HD."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   783   C0277793:disease onset [Temporal Concept]
   753   C0001779:Age [Organism Attribute]
   753   C0332162:Onset [Qualitative Concept]
Processing 00000000.tx.164: Am. 

Phrase: "Am."
Processing 00000000.tx.165: J. 

Phrase: "J."
Processing 00000000.tx.166: Hum. 

Phrase: "Hum."
Processing 00000000.tx.167: Genet., 53, 125130.[Medline] Shtilerman, M.D., Ding, T.T. and Lansbury, P.T. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "53,"

Phrase: "125130."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shtilerman,"

Phrase: "M.D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419419:DING [Gene or Genome]

Phrase: "T.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P.T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.168: Jr (2003) Molecular crowding accelerates fibrillization of -synuclein: could an increase in the cytoplasmic protein concentration induce Parkinson's disease? 

Phrase: "Jr (2003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: ")"

Phrase: "Molecular crowding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010383:Crowding [Social Behavior]
   861   C0040433:Crowding [Anatomical Abnormality]

Phrase: "accelerates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "fibrillization of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "could"

Phrase: "an increase in the cytoplasmic protein concentration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Parkinson's disease?"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.169: Biochemistry, 41, 38553860.[CrossRef]

Phrase: "Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "41,"

Phrase: "38553860."

Phrase: "[CrossRef"

Phrase: "]"

